Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koch

Showing results (511-520 of 726) with videos related to

Pageof 73
Sort By:
Frontiers in Neuroscience|December 13, 2021
Three-Dimensional Iron Oxide Nanoparticle-Based Contrast-Enhanced Magnetic Resonance Imaging for Characterization of Cerebral Arteriogenesis in the Mouse NeocortexTill de Bortoli, Philipp Boehm-Sturm, Stefan P Koch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 11, 2019
Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsisStan J F Hartman, Navin P Boeddha, Ebru Ekinci, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based DosingEveline E Roelofsen, Brenda C M de Winter, Heleen van der Spek, et al.
The Annals of Thoracic Surgery|September 1, 1992
A randomized study of the systemic effects of warm heart surgeryG T Christakis, J P Koch, K A Deemar, et al.
Clinical Pharmacokinetics|January 4, 2026
Population Pharmacokinetics of Intravenous Cefuroxime in Plasma and Bone of Patients with Prosthetic Joint Infection: Is There Room for Dose Optimization?Gerbert Coen de Waard, Qiaolin Zhao, Ewout S Veltman, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 19, 2019
Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertensionL E J Peeters, M P Kester, L Feyz, et al.
Nature Communications|February 22, 2020
Phase protection of Fano-Feshbach resonancesAlexander Blech, Yuval Shagam, Nicolas Hölsch, et al.
Annals of Clinical and Translational Neurology|March 14, 2025
If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain-Barré syndromeSander J van Tilburg, Ruth Huizinga, Krista Kuitwaard, et al.
Intensive Care Medicine|August 23, 2022
Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing softwareJason A Roberts, Rinaldo Bellomo, Menino O Cotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSFM Pfreundschuh, D Hasenclever, M Loeffler, et al.
Pageof 73

Showing results (511-520 of 726) with videos related to

Sort By:
Pageof 73
Frontiers in Neuroscience|December 13, 2021
Three-Dimensional Iron Oxide Nanoparticle-Based Contrast-Enhanced Magnetic Resonance Imaging for Characterization of Cerebral Arteriogenesis in the Mouse NeocortexTill de Bortoli, Philipp Boehm-Sturm, Stefan P Koch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 11, 2019
Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsisStan J F Hartman, Navin P Boeddha, Ebru Ekinci, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based DosingEveline E Roelofsen, Brenda C M de Winter, Heleen van der Spek, et al.
The Annals of Thoracic Surgery|September 1, 1992
A randomized study of the systemic effects of warm heart surgeryG T Christakis, J P Koch, K A Deemar, et al.
Clinical Pharmacokinetics|January 4, 2026
Population Pharmacokinetics of Intravenous Cefuroxime in Plasma and Bone of Patients with Prosthetic Joint Infection: Is There Room for Dose Optimization?Gerbert Coen de Waard, Qiaolin Zhao, Ewout S Veltman, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 19, 2019
Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertensionL E J Peeters, M P Kester, L Feyz, et al.
Nature Communications|February 22, 2020
Phase protection of Fano-Feshbach resonancesAlexander Blech, Yuval Shagam, Nicolas Hölsch, et al.
Annals of Clinical and Translational Neurology|March 14, 2025
If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain-Barré syndromeSander J van Tilburg, Ruth Huizinga, Krista Kuitwaard, et al.
Intensive Care Medicine|August 23, 2022
Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing softwareJason A Roberts, Rinaldo Bellomo, Menino O Cotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSFM Pfreundschuh, D Hasenclever, M Loeffler, et al.
Pageof 73